|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date31 Oct 1986 |
|
MechanismNMDA receptor antagonists [+1] |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date13 Aug 1947 |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseClinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Methapharm, Inc.
0 Patents (Medical) associated with Methapharm, Inc.
100 Deals associated with Methapharm, Inc.
100 Translational Medicine associated with Methapharm, Inc.